Analysed REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) News Sources
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures
20-05-2026
yahoo.com
Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement
15-07-2026
yahoo.com
Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study
12-08-2026
yahoo.com
Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
19-08-2026
yahoo.com
What is the current price of REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS)?
The current price of REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) is $0.0165.
REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) since the previous trading day is $0.0019.
REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) since the previous trading day is 13.0137%.
What is the most recent average sentiment score for REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS)?
The most recent average sentiment score for REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS)?
The most recent sentiment for REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS) is .
SEC-8K** Filing Available For REVIVE THERAPEUTICS LTD (RVVTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.